Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates
Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates

Agenus (AGEN) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $1.61. This compares to loss of $3.04 per share a year ago. These figures are

How to Find Strong Retail and Wholesale Stocks Slated for Positive Earnings SurprisesPhoto, wide shot, wide-angle lens,  Clothing manufacturer, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/4c710447-f68a-47bc-a682-c2d83e801596.png
How to Find Strong Retail and Wholesale Stocks Slated for Positive Earnings Surprises

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW
Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW

For Immediate Release

Chicago, IL – May 12, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the

Jack in the Box to Post Q2 Earnings: What's in Store for the Stock?
Jack in the Box to Post Q2 Earnings: What's in Store for the Stock?

Jack in the Box JACK is scheduled to report second-quarter fiscal 2025 results on May 14, after the closing bell. In the previous quarter, the company’s earnings surpassed the Zacks Consensus

How Should an Investor Play LUNR Stock Pre-Q1 Earnings Release?
How Should an Investor Play LUNR Stock Pre-Q1 Earnings Release?

Intuitive Machines, Inc. LUNR is slated to report first-quarter 2025 results on May 13, before market open.The Zacks Consensus Estimate for first-quarter revenues is pegged at $59.4 million

Cenovus Energy Q1 Earnings Beat on Higher Upstream Production
Cenovus Energy Q1 Earnings Beat on Higher Upstream Production

Cenovus Energy Inc. CVE reported first-quarter 2025 adjusted earnings per share of 32 cents, which beat the Zacks Consensus Estimate of 29 cents. The bottom line, however, declined from the year-ago

Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates
Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates

Surgery Partners (SGRY) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.10 per share a year ago. These

3 Stocks With Upgraded Broker Ratings to Navigate Market Uncertainties
3 Stocks With Upgraded Broker Ratings to Navigate Market Uncertainties

Stock markets have been experiencing significant volatility of late. This is largely because of the ongoing tariff war, which has also led to expectations of economic slowdown and rising inflation

Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?
Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?

Women’s health device maker, Hologic HOLX, slashed its earnings forecast for the full fiscal 2025, even as the latest second-quarter results topped expectations. The revenue target of $4.05-$4.10

SelectQuote (SLQT) Misses Q3 Earnings and Revenue Estimates
SelectQuote (SLQT) Misses Q3 Earnings and Revenue Estimates

SelectQuote (SLQT) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.05 per share a year ago. These

Chegg (CHGG) Reports Q1 Loss, Tops Revenue Estimates
Chegg (CHGG) Reports Q1 Loss, Tops Revenue Estimates

Chegg (CHGG) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.26 per share a year ago. These figures are

HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up
HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up

Haemonetics Corporation HAE delivered fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.24, which rose 37.8% year over year. The bottom line topped the Zacks Consensus Estimate by

ProAssurance Q1 Earnings Miss Estimates on Declining Premiums
ProAssurance Q1 Earnings Miss Estimates on Declining Premiums

Shares of ProAssurance Corporation PRA have remained relatively stable, falling only 0.3% since the company reported first-quarter 2025 results on May 6. The weaker-than-expected quarterly results

Walmart, Target and Amazon are part of Zacks Earnings Preview
Walmart, Target and Amazon are part of Zacks Earnings Preview

For Immediate Release

Chicago, IL – May 12, 2025 – Zacks.com releases the list of companies likely to issue earnings surprises. This week’s list includes Walmart WMT, Target TGT and Amazon AMZN.

Advantage Solutions Inc. (ADV) Reports Q1 Loss, Misses Revenue Estimates
Advantage Solutions Inc. (ADV) Reports Q1 Loss, Misses Revenue Estimates

Advantage Solutions Inc. (ADV) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of $0.06. This compares to loss of $0.16 per share a year ago. These figures are

Is the Options Market Predicting a Spike in Texas Instruments Stock?
Is the Options Market Predicting a Spike in Texas Instruments Stock?

Investors in Texas Instruments Incorporated TXN need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $85 Call had some of the

Here's How Much You'd Have If You Invested $1000 in Broadcom Inc. a Decade Ago
Here's How Much You'd Have If You Invested $1000 in Broadcom Inc. a Decade Ago

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors

Here's How Much a $1000 Investment in Leidos Made 10 Years Ago Would Be Worth Today
Here's How Much a $1000 Investment in Leidos Made 10 Years Ago Would Be Worth Today

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and

If You Invested $1000 in Netflix a Decade Ago, This is How Much It'd Be Worth Now
If You Invested $1000 in Netflix a Decade Ago, This is How Much It'd Be Worth Now

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and

Are Options Traders Betting on a Big Move in TripAdvisor Stock?
Are Options Traders Betting on a Big Move in TripAdvisor Stock?

Investors in Tripadvisor, Inc TRIP need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $8 Call had some of the highest implied

NRG Energy (NRG) Beats Q1 Earnings and Revenue Estimates
NRG Energy (NRG) Beats Q1 Earnings and Revenue Estimates

NRG Energy (NRG) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $1.80 per share. This compares to earnings of $0.80 per share a year ago. These figures

Macerich (MAC) Q1 FFO and Revenues Top Estimates
Macerich (MAC) Q1 FFO and Revenues Top Estimates

Macerich (MAC) came out with quarterly funds from operations (FFO) of $0.33 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to FFO of $0.31 per share a year ago

Upwork and PACCAR have been highlighted as Zacks Bull and Bear of the Day
Upwork and PACCAR have been highlighted as Zacks Bull and Bear of the Day

For Immediate Release

Chicago, IL – May 12, 2025 – Zacks Equity Research shares Upwork UPWK as the Bull of the Day and PACCAR PCAR as the Bear of the Day. In addition, Zacks Equity Research provides

Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates
Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates

Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.35 per share a year ago. These

BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates

BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $1.50 per share versus the Zacks Consensus Estimate of a loss of $2.72. This compares to loss of $13.92 per share a year ago